| Synonyms: | |
| Status: | Approved (2003) |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN |
| UNII: | 0343IGH41U |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| BINDING AGENT | B-lymphocyte antigen CD20 binding agent | FDA |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Lymphoma, Non-Hodgkin | 3 | D008228 | ClinicalTrials |
| Lymphoma | 3 | D008223 | ClinicalTrials |
| Lymphoma, Follicular | 2 | D008224 | ClinicalTrials |
| Lymphoma, Mantle-Cell | 2 | D020522 | ClinicalTrials |
| Leukemia, Lymphocytic, Chronic, B-Cell | 2 | D015451 | ClinicalTrials |
| Lymphoma, Follicular | 2 | D008224 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 208921-02-2 |
| ChEMBL | CHEMBL1201604 |
| FDA SRS | 0343IGH41U |
| Guide to Pharmacology | 6781 |
CONTENTS